Skip to main content
Article thumbnail
Location of Repository

Interleukin-1α enhances the aggressive behavior of pancreatic cancer cells by regulating the α6β1-integrin and urokinase plasminogen activator receptor expression

By Hirozumi Sawai, Yuji Okada, Hitoshi Funahashi, Yoichi Matsuo, Hiroki Takahashi, Hiromitsu Takeyama and Tadao Manabe
Topics: Research Article
Publisher: BioMed Central
OAI identifier:
Provided by: PubMed Central
Download PDF:
Sorry, we are unable to provide the full text but you may find it at the following location(s):
  • http://www.pubmedcentral.nih.g... (external link)
  • Suggested articles


    1. (1979). A: The use of avidin-biotin interaction in immunoenzymatic techniques.
    2. (2004). Abruzzese JL: Pancreatic cancer. Lancet
    3. (2004). AE: Extracellular alpha 6 integrin cleavage by urokinase-type plasminogen activator in human prostate cancer. Exp Cell Res
    4. (1995). AE: Integrin alpha 6 expression in human prostate carcinoma cells is associated with a migratory and invasive phenotype in vitro and in vivo. Clin Exp Metastasis
    5. (1993). Alpha 6 integrin is up-regulated in step increments accompanying neoplastic transformation and tumorigenic conversion of human fibroblasts. Cancer Res
    6. (2005). Ascites induces modulation of α6β1 integrin and urokinase plasminogen activator receptor expression and associated functions in ovarian carcinoma.
    7. (1992). Cano A: Expression of alpha 6 beta 4 integrin increases during malignant conversion of mouse epidermal keratinocytes: association of beta 4 subunit to the cytokeratin fraction. Exp Cell Res
    8. (2002). Ch: UICC TNM Classification of Malignant Tumors 6th edition.
    9. (1999). Chapman HA: A role for caveolin and the urokinase receptor in integrin-mediated adhesion and signaling.
    10. (2004). Cress AE: Integrin clipping: A novel adhesion switch?
    11. (2003). Downregulation of urokinase plasminogen activator receptor expression inhibits Erk signalling with concomitant suppression of invasiveness due to loss of uPAR-beta1 integrin complex in colon cancer cells.
    12. (1997). Elevated urokinase-type plasminogen activator receptor expression in a colon cancer cell line is due to a constitutively activated extracellular signal-regulated kinase-1-dependent signaling cascade. Oncogene
    13. (2006). Expression and prognostic roles of integrins andBMC Cell Biology
    14. (1993). Figdor CG: Regulation of integrin-mediated adhesion to laminin and collagen in human melanocytes and in non-metastatic and highly metastatic human melanoma cells.
    15. (1993). FM: Comparison of integrin expression and terminal differentiation capacity in cell lines derived from oral squamous cell carcinomas. Carcinogenesis
    16. (1995). GF: Differential display and integrin alpha 6 messenger RNA overexpression in hepatocellular carcinoma. Hepatology
    17. (2003). Gibbs JF: Evaluation of urinary plasminogen activator, its receptor, matrix metalloproteinase-9, and von Willebrand factor in pancreatic cancer. Clin Cancer Res
    18. (2005). Glycosaminoglycans modulate C6 glioma cell adhesion to extracellular matrix components and alter cell proliferation and cell migration.
    19. (2004). HS: Relationship between urokinase-type plasminogen receptor, interleukin-8 gene expression and clinicopathological features in gastric cancer. Oncology
    20. (1995). Integrins and signal transduction pathways: the road taken. Science
    21. (1992). Integrins: versatility, modulation, and signaling in cell adhesion. Cell
    22. (1996). KM: Integrins can collaborate with growth factors for phosphorylation of receptor tyrosine kinases and MAP kinase activation: roles of integrin aggregation and occupancy of receptors.
    23. (1999). L: Tumor dormancy induced by downregulation of urokinase receptor in human carcinoma involves integrin and MAPK signaling.
    24. (2001). Lowik C: Urokinase-receptor/integrin complexes are functionally involved in adhesion and progression of human breast cancer in vivo.
    25. (2000). M: β1 integrins play an essential role in adhesion and invasion of pancreatic carcinoma cells. Pancreas
    26. (2005). Manabe T: Activation of focal adhesion kinase enhances the adhesion and invasion of pancreatic cancer cells via extracellular signal-regulated kinase-1/2 signaling pathway activation. Mol Cancer
    27. (2003). Manabe T: Interleukin-1α enhances integrin α6β1 expression and metastatic capability of human pancreatic cancer. Oncology
    28. (1996). Mercurio AM: Function of the integrin alpha 6 beta 1 in metastatic breast carcinoma cells assessed by expression of a dominant-negative receptor. Cancer Res
    29. (1999). MP: Integrin α6β1 role in metastatic behavior of human pancreatic carcinoma cells.
    30. (2002). MS: Overexpression of alphavbeta6 integrin in serous epithelial ovarian cancer regulates extracellular matrix degradation via the plasminogen activation cascade. Carcinogenesis
    31. (1997). MW: Enhanced expression of urokinase plasminogen activator and its receptor in pancreatic carcinoma.
    32. (2004). Ohannessian A: Recruitment of focal adhesion kinase and paxillin to β1 integrin promotes cancer cell migration via mitogen activated protein kinase activation.
    33. (2004). OJ: Nerve growth factor stimulates MMP-2 expression and activity and increases invasion by human pancreatic cancer cells. Clin Exp Metastasis
    34. (2002). Petty HR: Molecular proximity of seprase and the urokinase-type plasminogen activator receptor on malignant melanoma cell membranes: dependence on beta1 integrins and the cytoskeleton. Carcinogenesis
    35. (1999). Proteolysis, cell adhesion, chemotaxis, and invasiveness are regulated by the u-PA-u-PAR-PAI-1 system. Thromb Haemost
    36. (2005). RC: Significant overexpression of urokinase-type plasminogen activator in pancreatic adenocarcinoma using real-time quantitative reverse transcription polymerase chain reaction.
    37. (2001). Regulation of urokinase plasminogen activator/plasmin-mediated invasion of melanoma cells by the integrin vitronectin receptor αvβ3.
    38. (1995). Saltiel AR: Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo. Nat Med
    39. (1981). Suppression of endogenous avidin-binding activity in tissues and its relevance to biotin-avidin detection systems.
    40. (1995). TE: Increase in suprabasilar integrin adhesion molecule expression in human epidermal neoplasms accompanies increased proliferation occurring with immortalization and tumor progression. Cancer Res

    To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.